Cyient DLM (CYIENTDLM) Q1 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 26/27 earnings summary
15 Oct, 2026Executive summary
Record Q1 FY27 performance; order book reached INR 25,989 Mn, with INR 551.9 Cr order intake and 1.5x book-to-bill.
Strategic roadmap prioritizes high-reliability EMS and expansion into AI infrastructure, data centers, robotics, and semiconductor capital equipment.
Financial highlights
Revenue was INR 3,738 Mn, up 34.3% YoY from INR 2,784 Mn; total income was INR 3,740.65 Mn.
EBITDA rose 56.2% to INR 392 Mn, with margin expanding 147 bps to 10.5%; PAT increased 118.2% to INR 163 Mn.
Finance costs declined 29.1% YoY to INR 61 Mn on lower working-capital borrowings; other income included a net forex loss of INR 20.55 Mn.
Basic and diluted EPS were INR 2.05, versus INR 0.94 a year earlier.
Outlook and guidance
FY27–29 strategy targets six industries, adding AI data centers and robotics, with 11–13% margins using the existing stack; FY30+ targets 13–18% margins through new platforms and product/IP expansion.
Growth focus includes power electronics, robotics, AI infrastructure/data centers, and expanded B2S products and platforms; new sectors are expected to support growth and margin expansion over 12–18 months.
Book-to-bill ratio expected to remain at 1.5x for the year.
Management expects the value of an investment in an IP communications company to improve as new products launch over the next few years.
Latest events from Cyient DLM
- Revenue rose 43.2% as Aerospace & Defense growth lifted FY24 results.CYIENTDLM
Q4 23/24 - Revenue and backlog hit records, but investment and mix weighed on Q2 margins.CYIENTDLM
Q2 26/27 - Q2 FY25 revenue up 33.4% YoY, with Altek acquisition boosting US growth and future EPS.CYIENTDLM
Q2 24/25 - Altek lifted Q3 revenue 38.4%, while adjusted PAT fell 9.8%.CYIENTDLM
Q3 24/25 - FY25 growth accelerated with Altek; top-customer softness weighed on Q4 standalone revenue.CYIENTDLM
Q4 24/25 - Record order intake lifted backlog as EBITDA grew and net profit declined.CYIENTDLM
Q1 25/26 - Backlog reached ₹22,911M as Q2 revenue fell 20.2% YoY after a large order ended.CYIENTDLM
Q2 25/26 - Backlog reached ₹23,494 Mn as normalized EBITDA margin rose to 10.2%.CYIENTDLM
Q3 25/26 - Record orders and improved normalized margins cushion FY26 revenue decline.CYIENTDLM
Q4 25/26